Restructuring Expenses

3 Months Ended

Mar. 31, 2017

Restructuring and Related Activities [Abstract]

Restructuring Expenses

Restructuring Expenses

On February 15, 2017, the Company announced its plan to reduce its workforce by approximately 100 full-time employees and close the Company’s Nashville, Tennessee and Slovenia facilities. The plan is expected to be completed in fiscal year 2017. The estimated total cost for the plan is $6.5 million, which includes estimated employee severance cost of approximately $3.9 million, and facility-related cost of approximately $2.6 million. During the three months ended March 31, 2017, the Company accrued $3.8 million of expenses, primarily for employee severance and related expenses, and paid out $2.1 million. The remaining unpaid balance of $1.7 million accrued expenses is presented as a component of accrued compensation in the Condensed Consolidated Balance Sheet. There were no facility-related costs incurred during the three months ended March 31, 2017.

The following table summarizes the restructuring expense recorded in each reportable segment and income statement classification for the three months ended March 31, 2017. There were no restructuring-related expenses recorded during the three months ended March 31, 2016.

	Automation and Analytics		Medication Adherence		Corporate		Total
	(in thousands)
Cost of revenue	$	1,266	$	431	$	—	$	1,697
Research and development	1,006		62		—		1,068
Selling, general and administrative	480		103		417		1,000
Total	$	2,752	$	596	$	417	$	3,765